A new study finds that the diabetes drug liraglutide significantly reduced monthly migraine days in patients with obesity and ...

Former FDA chief Dr. David Kessler says the new weight-loss drugs are a powerful tool to fight obesity. But they come with ...

If you’re experiencing chest pain that radiates to your neck, jaw, or arm, especially accompanied by sweating, shortness of breath, or nausea, these could be signs of a heart attack, and ...

Reference: “Incidence of medication-related osteonecrosis of the jaw and associated antiresorptive drugs in adult Finnish population” by Miika Kujanpää, Ville Vuollo, Antti Tiisanoja, Marja-Liisa ...

Weight-loss drugs continue to grow in popularity, with market researchers predicting that global demand for the medications could reach $150 billion by 2035. GLP-1 agonists — including ...

Researchers grouped patients who discontinued their obesity medications into those who discontinued early (within 3 months) and late (within 3-12 months). The study’s follow-up ended in December 2024.

Unpacking fertility, metabolism, and GLP-1 medications. From Ozempic babies to PCOS myths—Dr. Ilana Ressler clarifies the truth about fertility medications and metabolic wellness.

Glucagon-like peptide-1 agonists are a class of medications historically used to treat type 2 diabetes and manage blood sugar. In recent years, some of these drugs have also been approved to treat ...

A new report from American Specialty Health Incorporated details how GLP-1 usage isn’t being paired with proper exercise and diet often enough. 1 As the organization details, these medications help ...

Overall Medicaid spending on GLP-1 drugs — before partial rebates from drug manufacturers — jumped from $577.3 million in 2019 to $3.9 billion in 2023, according to a November report from KFF, a ...

Drugs that promise rapid and effortless weight loss once seemed like the stuff of fairytales. Now, even if we’re not “on the pen” ourselves, most of us know someone who is taking the much ...

A team of US and UK researchers revealed in the Diabetes, Obesity and Metabolism journal that up to one third of weight lost on GLP-1-based drugs is not body fat but other tissue, including muscle ...